Mechanism of inner membrane sigma-regulator function in Gram-negative bacteria

革兰氏阴性菌内膜西格玛调节功能的机制

• 批准号: 9316212
• 负责人: Christopher L Colbert
• 金额: $ 6万
• 依托单位: NORTH DAKOTA STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9316212
• 关键词: Adjuvant Therapy; Affinity; Antibiotic Resistance; Antibiotic Therapy; Antibiotics; Bacteria; Binding; Biochemical; Biological Models; Calorimetry; Cell surface; Cellular Assay; Centers for Disease Control and Prevention (U.S.); Complex; Cytoplasmic Tail; Development; Drug Delivery Systems; Environment; Equus caballus; Event; Face; Future; Genes; Genetic Transcription; Goals; Gram-Negative Bacteria; Health; Human; Infection; Inner Limiting Membrane; Iron; Lead; Mediating; Membrane; Membrane Transport Proteins; Metals; Modeling; Molecular Biology; Multi-Drug Resistance; N-terminal; NMR Spectroscopy; Nutrient; Prevalence; Process; Proteins; Proteolysis; Pseudomonas aeruginosa; Reporting; Research; Series; Siderophores; Signal Transduction; Specificity; Structure; System; Testing; Therapeutic; Thermodynamics; Time; Titrations; Transcriptional Activation; Transcriptional Regulation; Up-Regulation; Work; X-Ray Crystallography; base; biophysical techniques; combat; combinatorial; design; innovation; interdisciplinary approach; next generation; novel; novel therapeutics; pathogen; periplasm; prevent; protein protein interaction; resistance mechanism; response

DESCRIPTION (provided by applicant): The CDC recently released a report detailing antibiotic resistant threats in the US. Of particular emphasis in the CDC report is the increased prevalence of multidrug-resistant, Gram-negative bacteria (MDR- GNB) and the need to develop the next generation of antibiotics to combat them. All Gram-negative bacteria rely on a set of homologous, yet highly-specific, outer membrane TonB-dependent transporters (TBDTs) to import critical nutrients from their environment, especially metals like iron, which are bound by high-affinity, metal chelating compounds called siderophores. Recent antibiotic developments have shown that siderophore-antibiotic conjugates can be selectively targeted to specific bacteria, and that this delivery mechanism overcomes several key antibiotic resistance mechanisms. However, a significant limitation of this delivery system is the low expression levels of the TBDTs. The long-term objective of this proposal is to provide a mechanistic understanding of how Gram-negative bacteria transcriptionally regulate their TBDTs in order to manipulate this process to selectively up-regulate TBDT levels and enhance siderophore-antibiotic conjugate therapy for treatment of MDR-GNB infections. In this proposal we will elucidate the structural basis for protein interaction events that are responsible for up-regulatin the transcription of particular TBDTs. As a model system we are using the pseudobactin BN7/8 transport system from Psuedomonas putida that consists of the TBDT, PupB, the inner membrane σ-regulator, PupR, and the cytoplasmic σ-factor, PupI. To accomplish our objective we will pursue the following two specific aims: 1) delineate the mechanism by which the PupR:PupI interaction at the cytoplasmic face of the inner membrane is altered to allow transcriptional activation by PupI, and 2) establish the thermodynamics and atomic-level structural details of the interaction between the PupB and PupR. For the successful completion of our aims we will employ a multidisciplinary approach including NMR spectroscopy, X-ray crystallography, molecular biology, cellular assays, and biophysical techniques such as isothermal titration calorimetry. This research will provide the first structural information for a σ-regulator, explain how localization of a σ-factor to the inner membrane limits its activity, and th extent to which periplasmic interactions between the TBDT and σ-regulator lead to conformational changes that might be important for controlling transcriptional activation.

描述（由申请人提供）：疾病预防控制中心最近发布了一份报告，详细介绍了美国的抗生素耐药性威胁。 CDC 报告特别强调的是多重耐药革兰氏阴性菌 (MDR-GNB) 患病率的增加以及开发下一代抗生素来对抗它们的必要性。所有革兰氏阴性细菌都依靠一组同源但高度特异性的外膜 TonB 依赖性转运蛋白 (TBDT) 从环境中导入关键营养物质，尤其是铁等金属，它们与称为铁载体的高亲和力金属螯合化合物结合。最近的抗生素进展表明，铁载体-抗生素缀合物可以选择性地靶向特定细菌，并且这种递送机制克服了几种关键的抗生素耐药机制。然而，该递送系统的一个显着限制是 TBDT 的低表达水平。该提案的长期目标是提供对革兰氏阴性菌如何转录调节其 TBDT 的机制理解，以便操纵该过程选择性上调 TBDT 水平并增强铁载体-抗生素结合疗法治疗 MDR-GNB 感染。在本提案中，我们将阐明负责上调特定 TBDT 转录的蛋白质相互作用事件的结构基础。作为模型系统，我们使用来自恶臭假单胞菌的假杆菌素 BN7/8 转运系统，该系统由 TBDT、PupB、内膜 σ 调节因子 PupR 和细胞质 σ 因子 PupI 组成。为了实现我们的目标，我们将追求以下两个具体目标：1）描绘内膜细胞质面的 PupR：PupI 相互作用被改变以允许 PupI 转录激活的机制，2）建立 PupB 和 PupR 之间相互作用的热力学和原子级结构细节。为了成功实现我们的目标，我们将采用多学科方法，包括核磁共振波谱学、X 射线晶体学、分子生物学、细胞分析和等温滴定量热法等生物物理技术。这项研究将为 σ 调节器提供第一个结构信息，解释 σ 因子在内膜的定位如何限制其活性，以及​​ TBDT 和 σ 调节器之间的周质相互作用导致构象变化的程度，这可能对控制转录激活很重要。